At what enterprise value was BIOLINE AGROSCIENCES acquired in 2025?

You can find the full valuation details of BIOLINE AGROSCIENCES on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the AgriFood industry currently tracks an average EBITDA multiple of 10.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of BIOLINE AGROSCIENCES when it was acquired by EURAZEO?

The exact EV/EBITDA multiple for BIOLINE AGROSCIENCES is available on mynth capital. For comparison, the AgriFood sector currently shows an average EBITDA multiple of 10.6x. Join our community for free to access full valuation data and industry trends.

When was BIOLINE AGROSCIENCES acquired by EURAZEO?

BIOLINE AGROSCIENCES was acquired by EURAZEO in 2025.

What was the revenue of BIOLINE AGROSCIENCES at the time of the deal?

The revenue of BIOLINE AGROSCIENCES at the time of the deal is estimated to be in the range of 50M - 100M EUR. Register for free to access the full transaction report and exact valuation multiples.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the BIOLINE AGROSCIENCES acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the BIOLINE AGROSCIENCES deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://fr.newsroom.eurazeo.com/assets/eurazeo-epbf-premier-closing-communique-pdf-2b3f2-7ed35.html

← DATABASE

Home Database AgriFoodBIOLINE AGROSCIENCES

03/2025

BIOLINE AGROSCIENCES

Acquired by

EURAZEO

FRANCE Agriculture / Specialized & Indoor Farming REV 50M - 100M EUR

BIOLINE AGROSCIENCES acquired by EURAZEO

FRANCE Agriculture / Specialized & Indoor Farming REV 50M - 100M EUR

Context

The acquisition of Bioline Agrosciences by Eurazeo marks a significant milestone in the development of the company, providing it with the necessary resources and support to pursue its growth strategy. The deal is structured as a leveraged buyout (LBO), with Eurazeo acquiring a majority stake in the company. The investment thesis relies on the growth potential of the biocontrol sector, driven by increasing demand for sustainable and environmentally friendly practices in agriculture. Through this acquisition, Eurazeo aim to support the expansion of Bioline Agrosciences' product portfolio and its presence in key markets, including Europe, Africa, and North America. The deal also reflects the companies' commitment to ESG criteria, with a focus on reducing the environmental impact of agricultural practices. With a strong management team in place and a clear growth strategy, Bioline Agrosciences is well-positioned to capitalize on the growing demand for biocontrol solutions and create value for its investors.

BIOLINE AGROSCIENCES, which reported an EBITDA margin of LOGIN in 2023, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the AgriFood sector (10.6x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in AgriFood market trends

Target

Bioline Agrosciences is a subsidiary of Bioline, a French agricultural company, specializing in the development of macro-organisms, insects, and acariens that neutralize insect pests in crops without the use of phytosanitary products. The company's business model revolves around providing innovative, eco-friendly solutions to the agricultural industry, primarily targeting international markets where it generates approximately 85% of its sales. Bioline Agrosciences operates in the biocontrol sector, which is a growing segment of the agricultural industry, driven by increasing demand for sustainable and environmentally friendly practices. The company's product portfolio includes a range of biological control agents, which are distributed through various channels, including wholesale and retail partnerships. With a strong focus on research and development, Bioline Agrosciences aims to expand its product offerings and strengthen its position in key markets, including Europe, Africa, and North America.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2023

2022

Other operations with BIOLINE AGROSCIENCES

REFERENCES

Revenue range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of BIOLINE AGROSCIENCES by EURAZEO are reserved for mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: bioline agrosciences

Acquirer: eurazeo